Venus Remedies gets approval to market Meropenem in Spain EP News Bureau Jun 22, 2023 The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other…
Venus gets marketing authorisation for Meropenem EP News Bureau Nov 11, 2014 Meropenem is a last-resort drug of the carbapenem class of antibiotics which is used in intensive care units (ICUs) of hospitals
